NCT02758912View on ClinicalTrials.gov

Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

September 25, 2019

Study Completion Date

October 25, 2019

Conditions
Stroke, Not Specified as Hemorrhage or InfarctionAngina Pectoris
Interventions
DRUG

оral intake of study drug capsules; study drug - Cardionat ® (trimethylhydrazinium propionate dihydrate), oral capsules 250 mg

Trial Locations (1)

123098

"Federal State Budget Institution State Scientific Center of Russian Federation - the Federal Medical Biophysical Center named after A I Burnazyan (FSBI SSC FMBC name AI Burnazyan FMBA of Russia)", Moscow

All Listed Sponsors
lead

Burnasyan Federal Medical Biophysical Center

OTHER_GOV

NCT02758912 - Clinical Study of Medicinal Product Cardionat® Using in Health Athlete Volunteers | Biotech Hunter | Biotech Hunter